Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials

Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Methods Forty patients receiving 5 x 5 Gy in a phase II...

Full description

Saved in:
Bibliographic Details
Published in:Radiation oncology (London, England) Vol. 16; no. 1
Main Authors: Rades, Dirk, Cacicedo, Jon, Conde-Moreno, Antonio J, Segedin, Barbara, Lomidze, Darejan, Ciervide, Raquel, Hollaender, Niels H, Schild, Steven E
Format: Journal Article
Language:English
Published: BioMed Central Ltd 07-01-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Methods Forty patients receiving 5 x 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 x 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). Results After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 x 5 Gy and 87% after 10 x 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 x 5 Gy and 85% after 10 x 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). Conclusions 5 x 5 Gy in 1 week appeared similarly effective as 10 x 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 x 5 Gy and 10 x 3 Gy. Trial registration clinicaltrials.gov NCT03070431. Registered 27 February 2017. Keywords: Metastatic spinal cord compression, Radiotherapy alone, Local progression-free survival, Motor function, Ambulatory status, Overall survival
AbstractList In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Forty patients receiving 5 x 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 x 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 x 5 Gy and 87% after 10 x 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 x 5 Gy and 85% after 10 x 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). 5 x 5 Gy in 1 week appeared similarly effective as 10 x 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 x 5 Gy and 10 x 3 Gy.
Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study compared 5 x 5 Gy in 1 week to 10 x 3 Gy in 2 weeks in a prospective cohort. Methods Forty patients receiving 5 x 5 Gy in a phase II trial were matched 1:2 to 213 patients receiving 10 x 3 Gy in two previous prospective studies for tumor type, ambulatory status, time developing motor deficits, interval between tumor diagnosis and MSCC and visceral metastases. These factors were consistent in all three patients (triple) used for each 1:2 matching. Groups were compared for local progression-free survival (LPFS), motor function, ambulatory status, and overall survival (OS). Results After matching, 32 triples remained for analyses (N = 96 in total). Six-month LPFS-rates were 94% after 5 x 5 Gy and 87% after 10 x 3 Gy (p = 0.36), 6-month OS-rates 43% and 35% (p = 0.74). Improvement of motor function was achieved in 59% and 34% of patients (p = 0.028); overall response rates (improvement or no further progression of motor deficits) were 94% and 89% (p = 0.71). Post-treatment ambulatory rates were 81% after 5 x 5 Gy and 85% after 10 x 3 Gy (p = 0.61). Of non-ambulatory patients, 50% (6/12) and 46% (11/24) regained the ability to walk (p = 1.00). Conclusions 5 x 5 Gy in 1 week appeared similarly effective as 10 x 3 Gy in 2 weeks. These results may not be applicable to long-term survivors and should be confirmed in a randomized trial directly comparing 5 x 5 Gy and 10 x 3 Gy. Trial registration clinicaltrials.gov NCT03070431. Registered 27 February 2017. Keywords: Metastatic spinal cord compression, Radiotherapy alone, Local progression-free survival, Motor function, Ambulatory status, Overall survival
Audience Academic
Author Schild, Steven E
Conde-Moreno, Antonio J
Lomidze, Darejan
Hollaender, Niels H
Rades, Dirk
Cacicedo, Jon
Segedin, Barbara
Ciervide, Raquel
Author_xml – sequence: 1
  fullname: Rades, Dirk
– sequence: 2
  fullname: Cacicedo, Jon
– sequence: 3
  fullname: Conde-Moreno, Antonio J
– sequence: 4
  fullname: Segedin, Barbara
– sequence: 5
  fullname: Lomidze, Darejan
– sequence: 6
  fullname: Ciervide, Raquel
– sequence: 7
  fullname: Hollaender, Niels H
– sequence: 8
  fullname: Schild, Steven E
BookMark eNptUE1LQzEQDFLBtvoHPAU8p-bzpTmWolUoeOnBW8nLR430JY8kiv57U_TQgyw7s7PMzmFnYBJTdADcErwgZNndF8Iw4QhTjDCRTCJ5AaZE8iWSRL5OzuYrMCvlHWMuGFZTUNdpGHUOJUWYPBTwq_XmG-poIcFNsZPyKcPBVV2qrsHAMoaoj9CkbBsMY3alhBbwUUI8QKurhj6nAda37BwccyqjMzV8Olhz0MdyDS59I3fzx3Owe3zYrZ_Q9mXzvF5t0YEIWhG1sidMdpQojXnfO87UCSzXnGKpuBKUWCV65blYOsp4L4kwxlnFWK_YHNz9xh700e1D9KlmbYZQzH7VCSxUp4RorsU_rlbWDcG0N_vQ9mcHPy7wbdg
ContentType Journal Article
Copyright COPYRIGHT 2021 BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2021 BioMed Central Ltd.
DOI 10.1186/s13014-020-01737-7
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1748-717X
ExternalDocumentID A650596955
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
-A0
0R~
123
29P
2WC
3V.
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFS
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
HMCUK
HYE
I-F
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TUS
UKHRP
WOQ
WOW
~8M
ID FETCH-LOGICAL-g152t-2d7b1376219a04bbe439be43d4a4207949521d95b9f458e234b715cced933b93
ISSN 1748-717X
IngestDate Tue Nov 19 20:41:24 EST 2024
Tue Nov 12 22:50:58 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-g152t-2d7b1376219a04bbe439be43d4a4207949521d95b9f458e234b715cced933b93
ParticipantIDs gale_infotracmisc_A650596955
gale_infotracacademiconefile_A650596955
PublicationCentury 2000
PublicationDate 20210107
PublicationDateYYYYMMDD 2021-01-07
PublicationDate_xml – month: 01
  year: 2021
  text: 20210107
  day: 07
PublicationDecade 2020
PublicationTitle Radiation oncology (London, England)
PublicationYear 2021
Publisher BioMed Central Ltd
Publisher_xml – name: BioMed Central Ltd
SSID ssj0045309
Score 2.3418832
Snippet Background In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible....
In a palliative situation like metastatic spinal cord compression (MSCC), overall treatment time of radiotherapy should be as short as possible. This study...
SourceID gale
SourceType Aggregation Database
SubjectTerms Care and treatment
Complications and side effects
Development and progression
Dose-response relationship (Biochemistry)
Metastasis
Spinal cord compression
Title Comparison of 5 x 5 Gy and 10 x 3 Gy for metastatic spinal cord compression using data from three prospective trials
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9QwFLamRUJcKsoiulD5gMQhsshiZzmWYWgv5QBzqLhUSexUHEjQLFL59_2encXQguiBQ6yxM_GM8j69zW9h7I0qlG7SMBcmk9TCLDcil1KKFMqrpopVse2icP4l-3SZf1jIxWw29Eub1v4rpbEGWlPm7AOoPW6KBXwGzTGC6hj_ie5zv7FgoIIbXGeuyFIUYpbQjGILv5tNSelE3-pg_cP2xiJD1MaYu9jYNthaRwIFkQ5pKCtDiVXdkJ8Z2KYfa1_D_UzFDpwa2tauwNN9XUM8DwSecLwK7HfMG5qXNViY7noP_7iMfYy46Fam7fraB2BKnXe4Za5JHHtHKb5fI46sXyP7g4_bi3EiLp3JXMAOvXRC7J61gbWnv0P4rsSwB1jriExLQbY0WFSSiWySj2PU4im0WVWkhVI77FEMxmbzBd9_HSS_VIkNKRr_ypCklafv7v5ArwN42szyKdvrzRB-6vCzz2amfcYeX_SBFs_ZZoIR7xqu-A2us58clONRiFlCM8CITzDiDkacYMQ9GHELI04w4gQjbmHEPRhxB6MXbPlxsZyfi75Bh7iG2rcRsc6qCBIKUq8MZVUZaLc0aFnKOASnL6Ac6kJVRSNVbuJEVlmkaqAH764qkpdst-1a84pxqU1cwLRODDZKTFU2eZjEVaO0URRqcMDe0su6ItIBD3XZJ4_gaapfdjWR5oAd__JNcMvau33499tH7MmExWO2u1ltzWu2s9bbE-utObEEvwXb5YCS
link.rule.ids 315,782,786,866,27933,27934
linkProvider BioMedCentral
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+5+x+5+Gy+and+10+x+3+Gy+for+metastatic+spinal+cord+compression+using+data+from+three+prospective+trials&rft.jtitle=Radiation+oncology+%28London%2C+England%29&rft.au=Rades%2C+Dirk&rft.au=Cacicedo%2C+Jon&rft.au=Conde-Moreno%2C+Antonio+J&rft.au=Segedin%2C+Barbara&rft.date=2021-01-07&rft.pub=BioMed+Central+Ltd&rft.issn=1748-717X&rft.eissn=1748-717X&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs13014-020-01737-7&rft.externalDocID=A650596955
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1748-717X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1748-717X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1748-717X&client=summon